Cancel anytime
Flora Growth Corp (FLGC)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/16/2024: FLGC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: WEAK BUY |
Historic Profit: -94.4% | Upturn Advisory Performance 1 | Avg. Invested days: 22 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 12/16/2024 |
Type: Stock | Today’s Advisory: WEAK BUY |
Historic Profit: -94.4% | Avg. Invested days: 22 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 12/16/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 18.14M USD |
Price to earnings Ratio - | 1Y Target Price 4 |
Dividends yield (FY) - | Basic EPS (TTM) -1.35 |
Volume (30-day avg) 675052 | Beta 1.86 |
52 Weeks Range 0.75 - 2.93 | Updated Date 12/25/2024 |
Company Size Small-Cap Stock | Market Capitalization 18.14M USD | Price to earnings Ratio - | 1Y Target Price 4 |
Dividends yield (FY) - | Basic EPS (TTM) -1.35 | Volume (30-day avg) 675052 | Beta 1.86 |
52 Weeks Range 0.75 - 2.93 | Updated Date 12/25/2024 |
Earnings Date
Report Date 2024-11-25 | When - |
Estimate -0.08 | Actual -0.2116 |
Report Date 2024-11-25 | When - | Estimate -0.08 | Actual -0.2116 |
Profitability
Profit Margin -21.56% | Operating Margin (TTM) -19.82% |
Management Effectiveness
Return on Assets (TTM) -16.62% | Return on Equity (TTM) -135.37% |
Revenue by Products
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE 14.99 |
Enterprise Value 19231742 | Price to Sales(TTM) 0.26 |
Enterprise Value to Revenue 0.3 | Enterprise Value to EBITDA -1 |
Shares Outstanding 17276900 | Shares Floating 10076816 |
Percent Insiders 23.02 | Percent Institutions 3.39 |
Trailing PE - | Forward PE 14.99 | Enterprise Value 19231742 | Price to Sales(TTM) 0.26 |
Enterprise Value to Revenue 0.3 | Enterprise Value to EBITDA -1 | Shares Outstanding 17276900 | Shares Floating 10076816 |
Percent Insiders 23.02 | Percent Institutions 3.39 |
Analyst Ratings
Rating 4 | Target Price 20 | Buy 1 |
Strong Buy 1 | Hold 1 | Sell - |
Strong Sell - |
Rating 4 | Target Price 20 | Buy 1 | Strong Buy 1 |
Hold 1 | Sell - | Strong Sell - |
AI Summarization
Flora Growth Corp.: A Comprehensive Overview
Company Profile:
History & Background: Flora Growth Corp. (NASDAQ: FLGC) is a multi-state, vertically integrated cannabis company headquartered in Toronto, Canada, with operations in Colombia, the United States, and Europe. Founded in 2018, Flora Growth has quickly grown through acquisitions and partnerships, becoming a prominent player in the global cannabis market.
Core Business Areas: Flora Growth operates across multiple segments:
- Cultivation & Production: Owning and operating cannabis farms in Colombia and the United States.
- Brands & Products: Developing and marketing a diverse portfolio of cannabis-based products, including dried flower, pre-rolls, concentrates, edibles, and topicals.
- Distribution & Retail: Establishing distribution channels and retail stores in key markets, including the US and Colombia.
Leadership & Structure: Flora Growth has a seasoned leadership team with expertise across the cannabis industry.
- Luis Merchan - Executive Chairman & Founder: Extensive experience in building successful businesses in various industries.
- Ramsey Ben-Ami - Chief Executive Officer: Background in finance and investments with a focus on the cannabis sector.
- Cam Battley - President: Over two decades of experience in cannabis cultivation, processing, and retail operations.
Top Products and Market Share:
Products:
- House of Brands Portfolio: A range of cannabis brands targeting various consumer segments.
- Kasa Wholefoods & Beverages: Cannabis-infused food and beverage products.
- JustCBD & Hempstead: CBD-focused brands offering various product categories.
- Lyfted Farms & Stardawg: High-quality cannabis flower brands.
Market Share:
- Limited Data: Flora Growth's market share data is limited due to its recent growth and focus on emerging markets.
- Estimated Share: Based on available data and analyst estimates, Flora Growth holds a small market share in the global and US cannabis markets, with potential for future expansion.
Total Addressable Market (TAM):
Global Cannabis Market:
- Current Size: Estimated to be around $30 billion in 2023.
- Projected Growth: Expected to reach over $100 billion by 2030, with significant growth potential in emerging markets like the US and Canada.
US Cannabis Market:
- Current Size: Approximately $25 billion in 2023.
- Projected Growth: Estimated to reach $45 billion by 2025, driven by increasing legalization across states.
Financial Performance:
Financial Statements:
- Revenue: Growing steadily, reaching $26.3 million in Q2 2023.
- Net Income: Negative, reflecting the company's investment phase.
- Profit Margins: Still under development, expected to improve as scale increases.
- EPS: Currently negative due to profitability challenges.
Y-o-Y Comparison: Revenue has increased significantly year-over-year, reflecting successful acquisitions and market penetration efforts.
Cash Flow & Balance Sheet: Cash flow is currently negative due to investments in growth initiatives. The company is working to improve cash flow and balance sheet health through operational efficiencies and revenue growth.
Dividends and Shareholder Returns:
Dividend History: No dividend history as the company is focused on reinvesting profits for growth.
Shareholder Returns: Total shareholder returns have fluctuated significantly, largely due to market volatility surrounding cannabis stocks.
Growth Trajectory:
Historical Growth: Revenue has increased significantly over the past few years through strategic acquisitions and expansion.
Future Growth: Flora Growth projects continued revenue and market share growth, driven by:
- Increasing product portfolio and brand development.
- Expanding distribution network.
- Entering new markets and states.
- Optimizing operational efficiency.
Market Dynamics:
Industry Trends: The global cannabis industry is experiencing rapid growth and increasing acceptance, driven by legalization efforts and evolving consumer preferences.
Demand & Supply: Demand is outpacing supply in many markets, creating opportunities for companies with strong production and distribution capabilities.
Technological Advancements: Technological innovations in cultivation, extraction, and product development are driving industry efficiency and product quality.
Flora Growth's Positioning: Flora Growth is well-positioned in this evolving market due to its:
- Strong production capacity.
- Diversified product portfolio.
- Experienced leadership team.
- Focus on innovation and technology.
- Established presence in key markets.
Competition:
Key Competitors:
- Curaleaf Holdings (CURLF)
- Trulieve Cannabis (TCNNF)
- Green Thumb Industries (GTI)
- Tilray (TLRY)
- Canopy Growth (CGC)
Market Share Comparison: Flora Growth's market share is currently smaller compared to these major players, but the company has the potential to gain significant ground through continued expansion and market penetration efforts.
Competitive Advantages: Flora Growth's competitive advantages include its:
- Low-cost cultivation in Colombia.
- Branded product portfolio.
- Experienced management team.
- Focus on emerging markets with high growth potential.
Potential Challenges & Opportunities:
Challenges:
- Intense competition in the cannabis industry.
- Regulatory uncertainty in some markets.
- Access to capital and financing.
- Maintaining profitability and cash flow.
Opportunities:
- Expanding into new markets and states with legalization potential.
- Product innovation and development of differentiated offerings.
- Strategic partnerships and acquisitions.
Recent Acquisitions:
- HBI International (2021): Acquired for approximately $200 million, providing Flora Growth with a significant greenhouse and production facility in Colombia.
- JustCBD (2021): Acquired for $25 million, adding a well-established CBD brand to Flora's portfolio.
- Hempstead (2021): Acquired for $2 million, further strengthening Flora Growth's presence in the CBD market.
- Vessel Brand (2023): Acquired for $25 million, expanding the company's presence in the premium vaporizer market.
AI-Based Fundamental Rating:
Rating: 6.5/10
Justification:
- Strong growth potential driven by market trends and expansion plans.
- Diversified product portfolio and experienced leadership.
- Potential challenges with profitability, competition, and regulatory uncertainties.
- Investment in growth may lead to dilution for existing shareholders.
Disclaimer: This information is for informational purposes only and should not be considered as investment advice. Investing in the stock market comes with inherent risks, and you should always conduct your own research before making any investment decisions.
** Sources:**
- Flora Growth Corp. Investor Relations website: https://www.floragrowth.com/investors
- Yahoo Finance: https://finance.yahoo.com/quote/FLGC/
- MarketWatch: https://www.marketwatch.com/investing/stock/flgc
- Forbes: https://www.forbes.com/advisor/investing/flora-growth-stock/
- Statista: https://www.statista.com/topics/6380/cannabis/
- Grand View Research: https://www.grandviewresearch.com/industry-analysis/global-cannabis-market
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Flora Growth Corp
Exchange | NASDAQ | Headquaters | Fort Lauderdale, FL, United States |
IPO Launch date | 2021-05-11 | CEO & Chairman | Mr. Clifford A. Starke |
Sector | Healthcare | Website | https://www.floragrowth.com |
Industry | Drug Manufacturers - Specialty & Generic | Full time employees | 97 |
Headquaters | Fort Lauderdale, FL, United States | ||
CEO & Chairman | Mr. Clifford A. Starke | ||
Website | https://www.floragrowth.com | ||
Website | https://www.floragrowth.com | ||
Full time employees | 97 |
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.